| Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial A Bauer, M Schreinlechner, N Sappler, T Dolejsi, H Tilg, BA Aulinger, ... The Lancet Respiratory Medicine 9 (8), 863-872, 2021 | 93 | 2021 |
| Clopidogrel affects leukocyte dependent platelet aggregation by P2Y12 expressing leukocytes P Diehl, C Olivier, C Halscheid, T Helbing, C Bode, M Moser Basic research in cardiology 105 (3), 379-387, 2010 | 89 | 2010 |
| Role of microparticles in endothelial dysfunction and arterial hypertension T Helbing, C Olivier, C Bode, M Moser, P Diehl World journal of cardiology 6 (11), 1135, 2014 | 82 | 2014 |
| Enoxaparin for primary thromboprophylaxis in symptomatic outpatients with COVID-19 (OVID): a randomised, open-label, parallel-group, multicentre, phase 3 trial S Barco, D Voci, U Held, T Sebastian, R Bingisser, G Colucci, ... The Lancet Haematology 9 (8), e585-e593, 2022 | 50 | 2022 |
| Triple antithrombotic therapy in cardiac patients: more questions than answers M Moser, CB Olivier, C Bode European heart journal 35 (4), 216-223, 2014 | 49 | 2014 |
| Discontinuation of long term clopidogrel therapy induces platelet rebound hyperaggregability between 2 and 6 weeks post cessation P Diehl, C Halscheid, C Olivier, T Helbing, C Bode, M Moser Clinical Research in Cardiology 100, 765-771, 2011 | 45 | 2011 |
| Third generation P2Y12 antagonists inhibit platelet aggregation more effectively than clopidogrel in a myocardial infarction registry CB Olivier, P Diehl, K Schnabel, P Weik, Q Zhou, C Bode, M Moser Thrombosis and haemostasis 112 (02), 266-272, 2014 | 44 | 2014 |
| TRAP-induced platelet aggregation is enhanced in cardiovascular patients receiving dabigatran CB Olivier, P Weik, M Meyer, S Weber, N Anto-Michel, P Diehl, Q Zhou, ... Thrombosis Research 138, 63-68, 2016 | 40 | 2016 |
| Accuracy of a rapid diagnostic test for the presence of direct oral factor Xa or thrombin inhibitors in urine—a multicenter trial J Harenberg, J Beyer-Westendorf, M Crowther, J Douxfils, I Elalamy, ... Thrombosis and Haemostasis 120 (01), 132-140, 2020 | 37 | 2020 |
| Incidence, characteristics, and outcomes of myocardial infarction in patients with peripheral artery disease: insights from the EUCLID trial CB Olivier, H Mulder, WR Hiatt, WS Jones, FGR Fowkes, FW Rockhold, ... JAMA cardiology 4 (1), 7-15, 2019 | 32 | 2019 |
| Dabigatran and rivaroxaban do not affect AA-and ADP-induced platelet aggregation in patients receiving concomitant platelet inhibitors CB Olivier, P Weik, M Meyer, S Weber, P Diehl, C Bode, M Moser, Q Zhou Journal of thrombosis and thrombolysis 42, 161-166, 2016 | 30 | 2016 |
| Appropriateness of direct oral anticoagulant dosing in patients with atrial fibrillation: insights from the Veterans Health Administration GC Leef, AC Perino, M Askari, J Fan, PM Ho, CB Olivier, L Longo, ... Journal of Pharmacy Practice 33 (5), 647-653, 2020 | 29 | 2020 |
| The direct thrombin inhibitors dabigatran and lepirudin inhibit GPIbα-mediated platelet aggregation K Trabold, S Makhoul, S Gambaryan, J van Ryn, U Walter, K Jurk Thrombosis and haemostasis 119 (06), 916-929, 2019 | 23 | 2019 |
| Editorial comment: Reduction of oxidative stress: a new indication for acetylsalicylic acid in coronary artery bypass surgery P Diehl, C Olivier, C Bode, M Moser European Journal of Cardio-Thoracic Surgery 43 (6), 1163-1164, 2013 | 22 | 2013 |
| P2Y12 receptor blockers are anti-inflammatory drugs inhibiting both circulating monocytes and macrophages including THP-1 cells PM Siegel, L Sander, A Fricke, J Stamm, X Wang, P Sharma, N Bassler, ... Scientific reports 11 (1), 17459, 2021 | 19 | 2021 |
| Thrombin receptor antagonism in antiplatelet therapy C Olivier, P Diehl, C Bode, M Moser Cardiology and Therapy 2, 57-68, 2013 | 18 | 2013 |
| A high ratio of ADP–TRAP induced platelet aggregation is associated more strongly with increased mortality after coronary stent implantation than high conventional ADP induced … CB Olivier, K Schnabel, C Brandt, P Weik, M Olschewski, Q Zhou, C Bode, ... Clinical Research in Cardiology 103, 968-975, 2014 | 14 | 2014 |
| Platelet bone morphogenetic protein-4 mediates vascular inflammation and neointima formation after arterial injury M Jank, N von Niessen, CB Olivier, H Schmitt, N Anto-Michel, I Hilgendorf, ... Cells 10 (8), 2027, 2021 | 13 | 2021 |
| Central adjudication identified additional and prognostically important myocardial infarctions in patients undergoing percutaneous coronary intervention: results from CHAMPION … CB Olivier, DL Bhatt, S Leonardi, GW Stone, CM Gibson, PG Steg, ... Circulation: Cardiovascular Interventions 12 (7), e007342, 2019 | 13 | 2019 |
| Definitions of peri-procedural myocardial infarction and the association with one-year mortality: insights from CHAMPION trials CB Olivier, V Sundaram, DL Bhatt, S Leonardi, RD Lopes, VY Ding, ... International journal of cardiology 270, 96-101, 2018 | 13 | 2018 |
